Published on
Last updated on
NMPA Fast-Track Approvals: Applications and Approvals Passed
The NMPA (National Medical Products Administration) accepted 7 domestic and 1 overseas applications for fast-track approval and passed 2 other fast-track approvals for the following medical devices.
The “fast-track” for regulatory approval is a policy that was initiated in China from 2014. Whilst there have been no recent regulatory changes to the process, there has been an uptick in approvals as the system matures and more manufacturers seek to take advantage of the regulatory pathway.
AI software has been in the news frequently recently. Read our previous article about the developments for AI medical devices detecting diabetic retinopathy in conventional colour fundus photography.
By Jacky Li. Contact Cisema if you would like to learn more.
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.